Altered Behavior: An Infrequent Presentation with Levetiracetam

---

Case Report

Author Details : Nitin Patiyal, Amit Bhardwaj, Dinesh Kansal*, Atal Sood, Ankita Chauhan

Volume : 8, Issue : 2, Year : 2020

Article Page : 87-89

https://doi.org/10.18231/j.jpbs.2020.013

Suggest article by email

Get Permission

---

Abstract

Levetiracetam has been associated with aggressive behavior and mania.We are reporting a case of agitation and aggressive behavior following levetiracetam monotherapy for focal seizure prophylaxis. A 48 years old man, who presented to the neurology department with history of four episodes of sudden onset abnormal body movements. Patient was diagnosed with focal seizures with secondary generalization and was prescribed tablet levetiracetam 500 mg twice a day for seizure prophylaxis. Three weeks later patient presented with complaints of excessive sleepiness during daytime, agitation and aggressive behavior, though seizure free. According to World Health Organization Uppsala monitoring Centre (WHO-UMC) causality assessment system the case was classified as probable/likely for levetiracetam-induced altered behavior. Levetiracetam was discontinued, and tablet  carbamazepine controlled-release 300 mg twice daily was substituted. Within 2 days of switching therapy the agitation and aggression reduced substantially. Although levetiracetam has fewer side effects than traditional antiepileptic medications, but it is imperative to continuously monitor the patient for infrequent adverse effects also, so that required modifications to drug label may be done.

Keywords: Aggression, Agitation, Altered behavior, Levetiracetam.

How to cite : Patiyal N , Bhardwaj A , Kansal D , Sood A , Chauhan A , Altered Behavior: An Infrequent Presentation with Levetiracetam. J Pharm Biol Sci 2020;8(2):87-89

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.